![](https://news.europawire.eu/wp-content/uploads/2024/08/Tubulis-Recognized-as-One-of-2024s-Fierce-15-Biotechnology-Companies-by-Fierce-Biotech-144x144.jpg)
(IN BRIEF) Tubulis has been named one of 2024’s “Fierce 15” biotechnology companies by Fierce Biotech. This recognition celebrates Tubulis’ innovative work in ADC development and its commitment to improving cancer treatment outcomes. With significant recent advancements, including a €128 … Read the full press release